RMTI|EPS $0.15|Rev $69.3M|Internet Loss $5.3M
Rockwell Medical, Inc. is a healthcare firm that develops, manufactures, and distributes hemodialysis merchandise to dialysis suppliers worldwide.
For the complete yr 2025, the corporate reported income (web gross sales) of $69.3 million. The essential web loss per share (EPS) for the twelve months ended December 31, 2025, was $(0.15). For the fourth quarter of 2025, income was $18.3 million , with a primary web loss per share of $(0.01).
The corporate achieved a 21% gross margin within the fourth quarter of 2025. Moreover, Rockwell Medical reported $2.3 million in money circulation from working actions through the fourth quarter, ending the yr with $25.0 million in money.
This text was generated with the help of AI expertise and reviewed for accuracy. AlphaStreet could obtain compensation from firms talked about on this article. This content material is for informational functions solely and shouldn’t be thought of funding recommendation.
